Quarterly report pursuant to Section 13 or 15(d)

Condensed Balance Sheet

v3.7.0.1
Condensed Balance Sheet - USD ($)
Mar. 31, 2017
Dec. 31, 2016
Current Assets:    
Cash and cash equivalents $ 10,486,179 $ 11,578,473
Marketable securities 8,016,830 8,737,107
Prepaid expenses and other current assets 965,125 608,517
Total Current Assets 19,468,134 20,924,097
Security Deposits 30,785 30,785
Equipment, Net 83,688 88,650
Total Assets 19,582,607 21,043,532
Current Liabilities:    
Accounts payable and accrued expenses 1,715,486 1,882,500
Deferred Research and Development Arrangement 431,250 450,000
Other Liabilities 72,508 79,204
Warrant Liabilities 16,233,831 1,573,366
Total Liabilities 18,453,075 3,985,070
Commitments and Contingencies (note 14)
Stockholders' Equity:    
Preferred stock, par value $0.0001, 100,000,000 authorized shares, none issued and outstanding
Common stock, par value $0.0001, 500,000,000 authorized shares, 244,987,523 and 237,368,785 issued and outstanding 24,499 23,737
Additional paid-in capital 137,776,592 132,065,056
Stock subscription receivable (30,000)  
Accumulated other comprehensive loss (6,326) (6,122)
Accumulated deficit (136,635,233) (115,024,209)
Total Stockholders' Equity 1,129,532 17,058,462
Total Liabilities and Stockholders' Equity $ 19,582,607 $ 21,043,532